Yttrium‐90 radioembolization for intermediate‐advanced hepatocellular carcinoma: a phase 2 study V Mazzaferro, C Sposito, S Bhoori, R Romito, C Chiesa, C Morosi, ... Hepatology 57 (5), 1826-1837, 2013 | 564 | 2013 |
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial U Pastorino, M Rossi, V Rosato, A Marchiano, N Sverzellati, C Morosi, ... European Journal of Cancer Prevention 21 (3), 308-315, 2012 | 516 | 2012 |
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 499 | 2021 |
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label … A Gronchi, S Ferrari, V Quagliuolo, JM Broto, AL Pousa, G Grignani, ... The Lancet Oncology 18 (6), 812-822, 2017 | 457 | 2017 |
A geometrical characterization of integrable Hamiltonian systems through the theory of Poisson-Nijenhuis manifolds F Magri, C Morosi Dipartimento di Matematica" F. Enriques", Università degli Studi di Milano, 1984 | 305 | 1984 |
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 259 | 2022 |
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect S Stacchiotti, T Negri, N Zaffaroni, E Palassini, C Morosi, S Brich, E Conca, ... Annals of oncology 22 (7), 1682-1690, 2011 | 239 | 2011 |
High-grade soft-tissue sarcomas: tumor response assessment—pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria S Stacchiotti, P Collini, A Messina, C Morosi, M Barisella, R Bertulli, ... Radiology 251 (2), 447-456, 2009 | 237 | 2009 |
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group S Stacchiotti, A Gronchi, P Fossati, T Akiyama, C Alapetite, M Baumann, ... Annals of Oncology 28 (6), 1230-1242, 2017 | 204 | 2017 |
Response to imatinib plus sirolimus in advanced chordoma S Stacchiotti, A Marrari, E Tamborini, E Palassini, E Virdis, A Messina, ... Annals of Oncology 20 (11), 1886-1894, 2009 | 191 | 2009 |
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ... Annals of Oncology 32 (12), 1520-1536, 2021 | 189 | 2021 |
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups A Gronchi, E Palmerini, V Quagliuolo, J Martin Broto, A Lopez Pousa, ... Journal of Clinical Oncology 38 (19), 2178-2186, 2020 | 181 | 2020 |
Sunitinib malate in solitary fibrous tumor (SFT) S Stacchiotti, T Negri, M Libertini, E Palassini, A Marrari, B De Troia, ... Annals of oncology 23 (12), 3171-3179, 2012 | 174 | 2012 |
Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and … C Chiesa, M Mira, M Maccauro, C Spreafico, R Romito, C Morosi, ... European journal of nuclear medicine and molecular imaging 42, 1718-1738, 2015 | 171 | 2015 |
Response to sunitinib malate in advanced alveolar soft part sarcoma S Stacchiotti, E Tamborini, A Marrari, S Brich, SA Rota, M Orsenigo, ... Clinical Cancer Research 15 (3), 1096-1104, 2009 | 170 | 2009 |
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with 90Y microspheres: the experience of the National Tumor … C Chiesa, M Maccauro, R Romito, C Spreafico, S Pellizzari, A Negri, ... Quarterly Journal of Nuclear Medicine and Molecular Imaging 55 (2), 168, 2011 | 160 | 2011 |
Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm C Messiou, E Moskovic, D Vanel, C Morosi, R Benchimol, D Strauss, ... European Journal of Surgical Oncology (EJSO) 43 (7), 1191-1198, 2017 | 153 | 2017 |
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network S Stacchiotti, E Palassini, R Sanfilippo, B Vincenzi, MG Arena, ... Annals of oncology 23 (2), 501-508, 2012 | 153 | 2012 |
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series F Grosso, R Sanfilippo, E Virdis, C Piovesan, P Collini, P Dileo, C Morosi, ... Annals of Oncology 20 (8), 1439-1444, 2009 | 150 | 2009 |
Phase II study on lapatinib in advanced EGFR-positive chordoma S Stacchiotti, E Tamborini, SL Vullo, F Bozzi, A Messina, C Morosi, ... Annals of oncology 24 (7), 1931-1936, 2013 | 148 | 2013 |